Featured Research

from universities, journals, and other organizations

How Can We Regulate Medicines Better?

Date:
October 22, 2007
Source:
BMJ-British Medical Journal
Summary:
European drug regulations need changing to ensure they meet the needs of patients and doctors, argue experts. Licensing of new drugs in Europe is increasingly controlled by the European Medicines Agency, yet new drugs have only to show they are equivalent to current treatments rather than show superiority.

European drug regulations need changing to ensure they meet the needs of patients and doctors, argue experts in the British Medical Journal.

Licensing of new drugs in Europe is increasingly controlled by the European Medicines Agency (EMEA), yet new drugs have only to show they are equivalent to current treatments rather than show superiority.

This favours the interests of drug companies, say Silvio Garattini and Vittorio Bertele from the Mario Negri Institute for Pharmacological Research in Italy. They believe that new drugs should be required to have some added value to current treatments or be cheaper.

One way to ensure this would be to introduce some element of independent research by a non-profit organisation, they say. At present, manufacturers prepare the reports seeking approval for a new drug or a new indication and independent research occurs only after approval.

Another concern with the European agency is transparency, they write. Unlike the US Food and Drug Administration, the EMEA keeps almost all its information secret, yet there is no reason to hide toxicological and clinical information, which is essential to understand why a new drug has been approved or a new indication granted.

Other information they suggest should be made transparent includes the size of the majority that approved a given drug, the reasons of the minority for opposing approval, conflicts of interest, and post-marketing commitments and their fulfilment.

They also believe that the regulatory system is subject to bias and suspicion and call for the European pharmaco-vigilance system to be implemented.

They conclude: "Some of our suggestions will make the approval of new drugs and new indications more difficult and prolong the time needed for their introduction into the market. We may therefore need to be more flexible to encourage industrial research.

One possibility would be to prolong product patents in exchange for better, safer, more trustworthy, and more affordable innovation. We believe the changes will not only be important for patients but will help stimulate innovative research by drug companies."


Story Source:

The above story is based on materials provided by BMJ-British Medical Journal. Note: Materials may be edited for content and length.


Cite This Page:

BMJ-British Medical Journal. "How Can We Regulate Medicines Better?." ScienceDaily. ScienceDaily, 22 October 2007. <www.sciencedaily.com/releases/2007/10/071018171436.htm>.
BMJ-British Medical Journal. (2007, October 22). How Can We Regulate Medicines Better?. ScienceDaily. Retrieved October 22, 2014 from www.sciencedaily.com/releases/2007/10/071018171436.htm
BMJ-British Medical Journal. "How Can We Regulate Medicines Better?." ScienceDaily. www.sciencedaily.com/releases/2007/10/071018171436.htm (accessed October 22, 2014).

Share This



More Health & Medicine News

Wednesday, October 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Orthodontist Mom Jennifer Salzer on the Best Time for Braces

Orthodontist Mom Jennifer Salzer on the Best Time for Braces

Working Mother (Oct. 22, 2014) Is your child ready? Video provided by Working Mother
Powered by NewsLook.com
U.S. Issues Ebola Travel Restrictions, Are Visa Bans Next?

U.S. Issues Ebola Travel Restrictions, Are Visa Bans Next?

Newsy (Oct. 22, 2014) Now that the U.S. is restricting travel from West Africa, some are dropping questions about a travel ban and instead asking about visa bans. Video provided by Newsy
Powered by NewsLook.com
US to Track Everyone Coming from Ebola Nations

US to Track Everyone Coming from Ebola Nations

AP (Oct. 22, 2014) Stepping up their vigilance against Ebola, federal authorities said Wednesday that everyone traveling into the US from Ebola-stricken nations will be monitored for symptoms for 21 days. (Oct. 22) Video provided by AP
Powered by NewsLook.com
Doctors Help Paralysed Man Walk Again, Patient in Disbelief

Doctors Help Paralysed Man Walk Again, Patient in Disbelief

AFP (Oct. 22, 2014) Polish doctors describe how they helped a paralysed man walk again, with the patient in disbelief at the return of sensation to his legs. Duration: 1:04 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins